Home › Funds › CANNELL CAPITAL LLC › ETON

CANNELL CAPITAL LLC position in ETON

ETON PHARMACEUTICALS INC COM · Health Care

CANNELL CAPITAL LLC reported holding 170,747 shares of ETON (ETON PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$6.2M, representing 4.37% of its reported portfolio and ranking #10 among its reported holdings. CANNELL CAPITAL LLC has disclosed ETON holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)170.75K sh
Reported value held$6.18M
Portfolio Weight4.37%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CANNELL CAPITAL LLC's ETON position evolved

CANNELL CAPITAL LLC first disclosed a stake in ETON in Q4 2024 at 381,323 shares (US$5.1M). The position peaked in Q3 2025 at 455,405 shares, worth US$9.9M. Across 7 filings, CANNELL CAPITAL LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 170,747 shares valued at US$6.2M — a reduction of -171,238 shares quarter over quarter.. Notable position changes include a 81% increase in Q1 2025 (shares rose 10% over the following quarter), a 52% trim in Q4 2025 (shares rose 46% over the following quarter), a 58% increase in Q1 2026 (shares rose 47% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 381.32K $5.08M New
Q1 2025 691.37K $8.97M Add
Q2 2025 388.18K $5.53M Reduce
Q3 2025 455.40K $9.90M Add
Q4 2025 216.92K $3.67M Reduce
Q1 2026 341.99K $8.44M Add
Q2 2026 170.75K $6.18M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ETON and 13F data

ETON (ETON PHARMACEUTICALS INC COM) is a Health Care company. 64 other funds we track also report a position in ETON — the largest reported positions include Opaleye Management Inc. (US$103.5M), EcoR1 Capital, LLC (US$78.6M), Nantahala Capital Management, LLC (US$42.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ETON

All ETON fund holders →

FAQ

How long has CANNELL CAPITAL LLC held ETON?

CANNELL CAPITAL LLC has disclosed ETON holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is CANNELL CAPITAL LLC's current position in ETON?

As of Q2 2026, CANNELL CAPITAL LLC holds 170.75K shares of ETON (ETON PHARMACEUTICALS INC COM), valued at $6.18M, representing 4.37% of its reported portfolio and ranking #10.

Has CANNELL CAPITAL LLC been buying or selling ETON?

In the latest 13F filing (Q2 2026), CANNELL CAPITAL LLC reduced its position in ETON. The position peaked in Q3 2025 at 455.40K shares.

Which other funds hold ETON?

Other major institutional holders of ETON include Opaleye Management Inc., EcoR1 Capital, LLC, Nantahala Capital Management, LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.